Transverse Myelitis following SARS-COV-2 vaccination: a case report
DOI:
https://doi.org/10.14571/brajets.v19.n1.214-221Keywords:
Myelitis, Spinal Cord Inflammation, Postvaccinal Myelitis, COVID-19 Vaccines, ChAdOx1 nCoV-19Abstract
Acute transverse myelitis is a neuromedullary and autonomic disorder clinically characterized by motor and sensory dysfunctions below the level of spinal cord injury, resulting in significant neurological impairment. This condition has several etiologies, with infectious causes and rare post-vaccination reactions being the most relevant. This report presents a case study of transverse myelitis following SARS-CoV-2 vaccination in a patient from a city in southern Brazil. The study is a descriptive and retrospective case report. Reporting such a case is pertinent when it involves rare diagnoses, pioneering treatments, or unexpected outcomes in otherwise conventional scenarios. The case was defined based on clinical signs and symptoms, along with diagnostic tests that supported the diagnosis of transverse myelitis after SARS-CoV-2 immunization. Given the scarcity of studies and case reports on this condition in the context of vaccination, the present report is highly relevant to the medical and scientific community, as its findings may support accurate diagnosis in similar future cases.
References
Athayde, V. H. F. M., Lima, T. M. D. A. B., Andrade, G. M., Arruda, D. R. D., Ribeiro, M. M., Gonçalves, J. S., et al. (2021). Mielite transversa aguda: Repercussões clínicas e atualidades / Acute transverse myelitis: Clinical repercussions and current affairs. Brazilian Journal of Health Review, 4(6), 29174–29190.
Frohman, E. M., & Wingerchuk, D. M. (2010). Transverse myelitis. New England Journal of Medicine, 363(6), 564–572.
Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2022). Acute transverse myelitis following SARS-CoV-2 vaccination: A case report and review of literature. Journal of Neurology, 269(3), 1121–1132.
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., et al. (2022). Association between COVID-19 vaccination, SARS-CoV-2 infection, and risk of immune-mediated neurological events: Population-based cohort and self-controlled case series analysis. BMJ, e068373. https://doi.org/10.1136/bmj-2021-068373
Loz, S. H., Da Silva, G. F., Da Silva, C. F., Oliveira, R. E. N. D. N., Silva, F. W. D., Baptista, J. P. R., et al. (2022). Mielite transversa e vacina COVID-19: Uma associação temporal. Brazilian Journal of Infectious Diseases, 26, 101803.
Mărginean, C. O., Meliț, L. E., Cucuiet, M. T., Cucuiet, M., Rațiu, M., & Săsăran, M. O. (2022). COVID-19 vaccine—A potential trigger for MOGAD transverse myelitis in a teenager—A case report and a review of the literature. Children, 9(5), 674. https://doi.org/10.3390/children9050674
Martins, L. R., & Kashiwabara, T. G. B. (2020). Mielite transversa aguda: Revisão de literatura. Brazilian Journal of Surgery and Clinical Research, 30, 89–94.
Naeem, F. N., Hasan, S. F. S., Ram, M. D., Waseem, S., Ahmed, S. H., & Shaikh, T. G. (2022). The association between SARS-CoV-2 vaccines and transverse myelitis: A review. Annals of Medicine and Surgery, 79. https://doi.org/10.1016/j.amsu.2022.103870
Nguyen, S., Bastien, E., Chretien, B., Sassier, M., Defer, G., Nehme, A., et al. (2022). Transverse myelitis following SARS-CoV-2 vaccination: A pharmacoepidemiological study in the World Health Organization’s database. Annals of Neurology, 92(6), 1080–1089.
Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A., Iosifidis, C., et al. (2020). The socio-economic implications of the coronavirus pandemic (COVID-19): A review. International Journal of Surgery, 78, 185–193.
Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., et al. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 27(12), 2144–2153.
Rodríguez, Y., Rojas, M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Monsalve, D. M., et al. (2018). Guillain–Barré syndrome, transverse myelitis and infectious diseases. Cellular & Molecular Immunology, 15(6), 547–562.
Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): Clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.653786
Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., et al. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus. https://www.cureus.com/articles/63667-sars-cov-2-vaccination-induced-transverse-myelitis
Transverse myelitis in children and adults. (2023). In Handbook of Clinical Neurology (pp. 101–117). Elsevier. https://linkinghub.elsevier.com/retrieve/pii/B978032398817900020X
Van Doremalen, N., Lambe, T., Spencer, A., Belij-Rammerstorfer, S., Purushotham, J. N., Port, J. R., et al. (2020). ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. bioRxiv. https://doi.org/10.1101/2020.05.13.093195
Wahid, M., Jawed, A., Mandal, R. K., Areeshi, M. Y., El-Shall, N. A., Mohapatra, R. K., et al. (2023). Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: An update. Minerva Medica, 114(5). https://www.minervamedica.it/index2.php?show=R10Y2023N05A0683
Wilder-Smith, A., & RF, A. (2020). WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination. World Health Organization. https://researchonline.lshtm.ac.uk/id/eprint/4658098
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Débora Santos Souza, Emyr Hiago Bellaver, Paula Carolina Kath
This work is licensed under a Creative Commons Attribution 4.0 International License.
The BRAJETS follows the policy for Open Access Journals, provides immediate and free access to its content, following the principle that making scientific knowledge freely available to the public supports a greater global exchange of knowledge and provides more international democratization of knowledge. Therefore, no fees apply, whether for submission, evaluation, publication, viewing or downloading of articles. In this sense, the authors who publish in this journal agree with the following terms: A) The authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License (CC BY), allowing the sharing of the work with recognition of the authorship of the work and initial publication in this journal. B) Authors are authorized to distribute non-exclusively the version of the work published in this journal (eg, publish in the institutional and non-institutional repository, as well as a book chapter), with acknowledgment of authorship and initial publication in this journal. C) Authors are encouraged to publish and distribute their work online (eg, online repositories or on their personal page), as well as to increase the impact and citation of the published work.